To assure the optimal viewing experience, please review the
Systems Requirement Information
before viewing the presentations listed below.


Thursday, April 14, 2005


Welcome and Announcements
Presented by: Daniel S. Duick, MD, FACP, FACE
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)


Use of Diagnostic Ultrasound for Assessing Thyroid Nodules for Ug-FNA;
Controversies Regarding Nodule Size and Criteria for Aspiration

Presented by: Enrico Papini
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)



Ultrasound Guided Fine Needle Aspiration (FNA) and Core Needle
Biopsy (CNB) of Thyroid Nodules
Presented by: Daniel S. Duick, MD, FACP, FACE
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)



Ultrasound Characteristics of Benign and Malignant Lymphadenopathy in Preoperative and Postoperative Thyroid Cancer Patients
Presented by: Susan J. Mandel, MD MPH
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)



Surveillance of Post-op Thyroid Cancer Patients Utilizing
Ultrasound-Guided FNA Cytology and Needle Washout Analysis

Presented by: H. Jack Baskin, MD, MACE
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)




Friday, April 15, 2005


Welcome and Introductions
Presented by:
Paul W. Ladenson, ATA President
Gregory Brent, ATA Secretary
Steven Sherman, ATA Program Chair
James Fagin, ATA Program Chair
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)



Friday Keynote
Genetic Basis of Colorectal Neoplasia
Presented by: Bert Vogelstein
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)



Epidemiology/genetic Epidemiology
Secular Trends in Cancer Incidence
Presented by: Arthur Schneider
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)

Hereditary Medullary Thyroid Carcinoma
Presented by: Robert F. Gagel, MD
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)

Genetic Counseling and the Practice of Clinical Cancer Genetics
Presented by: Charis Eng, MD, PhD
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)

Familial Nonmedullary Cancer
Presented by: Carl D. Malchoff, MD, PhD
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)



Work-up and Diagnosis
Moderator: Hossein Gharib
Sonographic Prediction of Malignancy in Thyroid Nodules
Presented by: Susan J. Mandel, MD MPH
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)

Fine Needle Aspiration Biopsy
Presented by: Zubair W. Baloch, MD, PhD
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)



Surgery
Moderators: R. Michael Tuttle and Douglas Evans
Case Based - Extent of Surgery; Extent of Nodal Surgery; Management of
Surgical Complications
Presented by: Ashok Shaha, John Ridge, Gregory Randolph, Thomas McCaffrey
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)



Pathogenesis of Papillary Thyroid Cancer
Moderator: Bryan McIver
Expression Profiling of Thyroid Cancer
Presented by: Thomas Giordano
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)

The RET/PTC Oncogene in Thyroid Cancer Inflammation and Autoimmunity
Presented by: Jay L. Rothstein, PhD
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)



CME Symposium: Thyroid Hormone Suppression Therapy
Moderator: Mary Samuels
Impact on the Cancer
Presented by: Paul W. Ladenson, MD
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)

Impact on the Heart
Presented by: Irwin Klein, MD
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)

Impact on the Bone
Presented by: Graham R. Williams
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)




Saturday, April 16, 2005


Welcome and Introductions
Presented by:
Paul W. Ladenson, ATA President
Gregory Brent, ATA Secretary
Steven Sherman, ATA Program Chair
James Fagin, ATA Program Chair
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)



Saturday Keynote
New Paradigms in the Management of Differentiated Thyroid Cancer
Supported by an educational grant from Abbott Laboratories
Presented by: Ernest L. Mazzaferri, MD MACP
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)



Adjuvant Therapy
Supported by an educational grant from Genzyme, Inc.
Moderators: Stephanie Lee and Edward Silberstein

Radioiodine Therapy
Presented by: Steven I. Sherman, MD
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)

Preparation for Radioiodine Therapy
Presented by: Christoph Reiners
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)

Early Complications of Radioiodine Therapy
Presented by: Richard T. Kloos, MD
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)

Adjuvant External Beam Radiation Therapy for Differentiated Thyroid Cancer
Presented by: James Brierley
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)



Follow-up and Surveillance
Moderator: Gregory Brent

Imaging and Intervention with Ultrasound
Presented by: Enrico Papini
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)

PET
Presented by: Sophie Leboulleux
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)

Medullary Carcinoma
Presented by: Douglas W. Ball, MD
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)



Therapy for Advanced Disease
Moderator: David Cooper
Conventional Systemic Therapies
Presented by: Martin J. Schlumberger
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)

Surgical Treatment of Locally Advanced Disease
Presented by: Gary L. Clayman, DDS, MD, FACS
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)



Targeted Therapies for Thyroid Cancer
Supported by an educational grant from Abbott Laboratories
Moderator: Massimo Santoro

Overview of Targeted Therapy
Presented by: James A. Fagin
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)

Tyrosine Kinase Antagonists
Presented by: Matthew D. Ringel, MD
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)

Agents Inducing Epigenetic Modifications and their Potential Role as Targeted
Therapies for Refractory Thyroid Carcinoma
Presented by: Nicholas J. Sarlis
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)



Clark T. Sawin Historical Lecture 2005
The Seeds of Thyroid Cancer Research: The American Thyroid Association in the 1950s
Presented by: Gregory A. Brent, MD
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)




Sunday, April 17, 2005


Welcome and Introductions
Presented by:
Paul W. Ladenson, ATA President
Gregory Brent, ATA Secretary
Steven Sherman, ATA Program Chair
James Fagin, ATA Program Chair
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)



Role of rhTSH
Supported by an educational grant from Genzyme, Inc.
Moderator: Richard J. Robbins, MD

Imaging
Presented by: Richard J. Robbins, MD
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)

Thyroglobulin
Presented by: Bryan R. Haugen, MD
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)

RAI Therapy
Presented by: Furio Pacini, MD
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)



Cancer Following Radioiodine Therapy
Presented by: Elaine Ron
View Presentation (Windows Compatible)
View Presentation (Mac Compatible)



Tying It All Together: Management of the Thyroid Cancer Patient
Supported by an educational grant from Abbott Laboratories
Presented by: David Cooper

View Presentation (Windows Compatible)
View Presentation (Mac Compatible)


Powered by: